Physician profile
Annu Navani
NPI 1578699385
$2,955.98
in general payments reported to CMS, 2019-2025
15 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $603 · 2021: $470 · 2022: $826 · 2023: $229 · 2024: $368 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $762.79 | 2021-2022 | |
| Abbott Laboratories | $569.57 | 2019-2024 | Eterna |
| Vertos Medical, INC. | $504.38 | 2020 | |
| Curonix LLC | $239.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $184.23 | 2020-2022 | |
| Saluda Medical Americas, INC. | $182.47 | 2023 | Evoke Scs |
| Boston Scientific Corporation | $146.45 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $124.60 | 2019 | |
| Spr Therapeutics, INC | $73.31 | 2024 | Sprint Pns System |
| Electronic Waveform Lab, INC. | $41.53 | 2021-2022 | |
| Mml US, INC. | $40.47 | 2025 | Reactiv8 |
| Stryker Corporation | $28.10 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $22.81 | 2022 | |
| Abbvie INC. | $17.98 | 2023 | |
| Masimo Corporation | $17.58 | 2024 | Patient Safetynet System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annu Navani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.